CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Brown Dennis M Chief Scientific Officer | Other acquisition | +363 | 5,302 | ||
| 2022-08-01 | Praill Anthony Scott Chief Financial Officer | Grant or award | +240,087 | 277,273 | ||
| 2022-08-01 | Praill Anthony Scott Chief Financial Officer | Grant or award · Option (right to buy) | +720,260 | 720,260 | ||
| 2022-08-01 | Brown Dennis M Chief Scientific Officer | Grant or award | +240,087 | 246,905 | ||
| 2022-08-01 | Brown Dennis M Chief Scientific Officer | Grant or award · Option (right to buy) | +720,260 | 720,260 | ||
| 2022-08-01 | Hoffman Robert E. President and CEO | Grant or award | +400,145 | 455,145 | ||
| 2022-08-01 | Hoffman Robert E. President and CEO | Grant or award · Option (right to buy) | +1,200,634 | 1,200,634 | ||
| 2022-07-01 | SEYMOUR TAMARA A Director | Grant or award · Options (Right to Buy) | +100,000 | 100,000 | ||
| 2022-07-01 | TOTH ROBERT JOSEPH JR Director | Grant or award · Options (Right to Buy) | +100,000 | 100,000 | ||
| 2022-07-01 | Johnson Laura L. Director | Grant or award · Options (Right to Buy) | +100,000 | 100,000 | ||
| 2022-02-15 | Hoffman Robert E. President and CEO | Purchase | +55,000 | $0.47 | $26K | 55,000 |
| 2021-12-08 | Praill Anthony Scott Chief Financial Officer | Purchase | +28,700 | $0.68 | $19K | 37,186 |
| 2021-12-07 | Zarrabian Saiid Head of Strategic Partnerships | Purchase | +38,109 | $0.64 | $24K | 55,500 |
| 2021-12-06 | Zarrabian Saiid Head of Strategic Partnerships | Purchase | +11,891 | $0.59 | $7K | 17,391 |
| 2021-11-22 | Johnson Laura L. Director | Purchase | +3,000 | $0.74 | $2K | 3,000 |
| 2021-11-08 | HOFFMAN ROBERT President and CEO | Grant or award · Options (Right to Buy) | +3,519,170 | 3,519,170 | ||
| 2021-09-22 | Murphy Keith Director | Grant or award · Options (Right to Buy) | +100,000 | 100,000 | ||
| 2021-09-22 | TOTH ROBERT JOSEPH JR Director | Grant or award · Options (Right to Buy) | +100,000 | 100,000 | ||
| 2021-09-22 | SEYMOUR TAMARA A Director | Grant or award · Options (Right to Buy) | +35,000 | 35,000 | ||
| 2021-09-22 | HOFFMAN ROBERT Director | Grant or award · Options (Right to Buy) | +100,000 | 100,000 |
Page 3 of 18 · 357 trades